Healius Ltd
HLS: XASX (AUS)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
A$4.40 | Xgrz | Kwssmpnp |
Budget Outcome for Pathology Providers Broadly in Line With Our Expectations; Industry Undervalued
Top pathology providers remain significantly undervalued following the supportive pathology policy changes announced in the federal budget.